Abstract
Cardiovascular disease remains a leading cause of morbidity and mortality worldwide. Although technological and pharmaceutical advances have enhanced patient survival post-acute myocardial infarction (MI), both incidence and prevalence of post-MI leading to heart failure (HF) have continually climbed. Accordingly, it is important to identify treatable conditions potentially contributive to HF progression. Obstructive sleep apnea (OSA), a sleep breathing disorder in which chronic intermittent hypoxia (CIH) is the primary pathology, is associated with multiple cardiovascular diseases.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
